689b20e4e97c8.pdf
DOI:
Mavjud emas
1.Ottaviani, G., & Jaffe, N. (2009). The epidemiology of osteosarcoma. Cancer Treatment and Research, 152, 3-13.2.Bielack, S. S., et al. (2002). Prognostic factors in high-grade osteosarcoma of the extremities or trunk: An analysis of 1,702 patients. Journal of Clinical Oncology, 20(3), 776-790.3.Costelloe, C. M., et al. (2009). Imaging in osteosarcoma. Journal of Clinical Oncology, 27(32), 5326-5331.4.Kaste, S. C. (2008). Imaging pediatric bone sarcomas. Radiologic Clinics, 46(3), 455-471.5.Iyer, R., et al. (2013). The diagnostic and prognostic value of MRI in osteosarcoma. Pediatric Radiology, 43(10), 1237–1245.6.Huang, J., et al. (2012). Roleof PET/CT in the staging and evaluation of treatment response in pediatric sarcomas. Pediatric Radiology, 42(10), 1180-1189.7.Eary, J. F., et al. (2011). Quantitative FDG PET in sarcoma patients: Metabolic response as a prognostic indicator. Radiology, 261(2), 511-520.8.Franzius, C., & Schober, O. (2006). Role of PET and PET/CT in the diagnosis and management of bone sarcomas. Eur J Nucl Med Mol Imaging, 33(10), 1125-1132.9.Weiss, J., et al. (2021). Advancements in multimodal imaging for pediatric oncology. Pediatric Blood & Cancer, 68(7), e28934..